Mitochondrial Function in Patients With Severe Liver Disease (SLDglyc)
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Terminated
Unable to recruit. Only 2 subjects completed.
Other terminated trials from National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Healthy Volunteers · Mar 2026
- Cystic Fibrosis · Jan 2026
- ANCA Associated Vasculitis · Phase NA · Feb 2025
- Diabetes Mellitus, Type 1 · Phase PHASE2 · Dec 2024
- Overweight and Obesity · Phase PHASE4 · Oct 2024
See all terminations from National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Other Hepatic Insufficiency trials with similar outcome
This NA trial investigates Hepatic Insufficiency and Hypoalbuminemia and is currently terminated or withdrawn. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) leads this study, which shows 10 recorded versions since 2015 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Apr 2022 — Jul 2024 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Oct 2021 — Apr 2022 [monthly]
Recruiting NA
-
May 2021 — Oct 2021 [monthly]
Recruiting NA
▶ Show 5 earlier versions
-
Jan 2021 — May 2021 [monthly]
Recruiting NA
-
May 2020 — Jan 2021 [monthly]
Recruiting NA
-
May 2019 — May 2020 [monthly]
Recruiting NA
-
Jun 2018 — May 2019 [monthly]
Recruiting NA
-
Jan 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Oct 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- National Institutes of Health (NIH)
- University of Texas Southwestern Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .